Complement biomarkers reflect the pathological status of neuromyelitis optica spectrum disorders

Complement is involved in the pathogenesis of neuroimmune disease, but the detailed pathological roles of the complement pathway remain incompletely understood. Recently, eculizumab, a humanized anti-C5 monoclonal antibody, has been clinically applied against neuroimmune diseases such as myasthenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyamoto, Katsuichi, Minamino, Mai, Kuwahara, Motoi, Tsujimoto, Hiroshi, Ohtani, Katsuki, Wakamiya, Nobutaka, Katayama, Kei-ichi, Inoue, Norimitsu, Ito, Hidefumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020620/
https://www.ncbi.nlm.nih.gov/pubmed/36936980
http://dx.doi.org/10.3389/fimmu.2023.1090548

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020620/
https://www.ncbi.nlm.nih.gov/pubmed/36936980
http://dx.doi.org/10.3389/fimmu.2023.1090548

Ejemplares similares